The Use of Selective Progestin Receptor Modulators (SPRMs) and More Specifically Ulipristal Acetate in the Practice of Gynaecology

Australian and New Zealand Journal of Obstetrics and Gynaecology - United States
doi 10.1111/ajo.12641
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids With a Focus on Ulipristal Acetate

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Anatomically-Specific Actions of Oestrogen Receptor in the Developing Female Rat Brain: Effects of Oestradiol and Selective Oestrogen Receptor Modulators on Progestin Receptor Expression

Journal of Neuroendocrinology
Molecular NeuroscienceEndocrineEndocrinologyAutonomic SystemsCellularMetabolismDiabetes
2012English

The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice

Current Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2013English

Expanding the Therapeutic Use of Androgens via Selective Androgen Receptor Modulators (SARMs)

Drug Discovery Today
Drug DiscoveryPharmacology
2007English

Selective Estrogen Receptor Modulators

2006English

Ulipristal Acetate for Emergency Contraception?

The Lancet
Medicine
2010English

Emergency Contraception: Potential Role of Ulipristal Acetate

International Journal of Women's Health
GynecologyOncologyMidwiferyMaternityObstetrics
2010English

The Past, Present, and Future of Selective Progesterone Receptor Modulators in the Management of Uterine Fibroids

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2018English

The Clinical Pharmacology and Pharmacokinetics of Ulipristal Acetate for the Treatment of Uterine Fibroids

Reproductive Sciences
GynecologyObstetrics
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy